ClinicalTrials.Veeva

Menu

Mandibular Advancement Device and Changes in Nocturia (MAD)

F

Fernanda Yanez Regonesi

Status

Enrolling

Conditions

Nocturia
OSA
Obstructive Sleep Apnea

Treatments

Device: Somnodent Classic

Study type

Interventional

Funder types

Other

Identifiers

NCT05562388
177 - DR - 22 (Other Identifier)
DENT-22-MAD

Details and patient eligibility

About

The main purpose of this study is to test is mandibular advacenment device (MAD) use is associated with reductions in nocturia.

Full description

After been informed about the study and informed about risks and benefits, participants will be fitted with a MAD and will be asked to completed questionnaires at baseline, in between follow ups and during follow ups. Nocturia will be assess and appliance will be titrated every 2 weeks until participants report less than 2 voiding per night according to the daily dairies. At that point, second sleep study with MAD in place will be performed to assess treatment effectiveness.

Enrollment

36 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • English speaker
  • >18 y/o
  • Obstructive sleep apnea diagnosis with AHI≥5
  • ≥ 2 voiding/night at baseline
  • Upon clinical examination ≥ 8 teeth per arch, range of mandibular protrusion ≥5 mm
  • Consent to participate in the study.

Exclusion criteria

  • Patients with concomitant diagnosed sleep disorders (i.e. insomnia, narcolepsy, restless legs syndrome, rapid eye movement sleep behavior disorder).
  • Prostate/kidney problems (urological disease: (eg overactive bladder, benign prostate hyperplasia)
  • Pregnancy
  • Heart failure, use of diuretics, diabetes, Parkinson's disease or dementia.
  • Patients using combination therapy for the management of obstructive sleep apnea (OSA) (i.e. positive airway pressure (PAP) therapy or positional therapy).
  • Upon clinical examination: periodontal disease (>4 mm on periodontal probing, with bleeding on probing, visual signs of periodontal inflammation); tooth horizontal mobility >1 mm, vertical mobility, and unfavorable crown to root ratio; open cavities, loose or fractured restorations, or patient undergoing restorative dental treatments.
  • Exaggerated gag reflex.
  • Lack of coordination or dexterity.
  • Inadequate English comprehension.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

36 participants in 1 patient group

MAD therapy
Experimental group
Description:
MAD Therapy
Treatment:
Device: Somnodent Classic

Trial contacts and locations

1

Loading...

Central trial contact

Fernanda Yanez Regonesi, DDS, MS; Isabel Moreno Hay, DDS, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems